To confirm the antigen-binding specificity of 1G12-DOTA-Gd, we performed flow cytometry using Cy5-labeled 1G12-DOTA-Gd on HCC cell lines with varying levels of GPC3 expression. The gene discussed is GPC3; the disease is hepatocellular carcinoma.